User's profile image
Illinois Bone and Joint Institute
Rheumatologist
Talks (153)
Air Time: 633:29:42
Jak therapy for juvenile dermatomyositis
Mar 18
Denosumab may lower diabetes risk
Mar 18
communicating bad news
Mar 18
Medicare physician pay cuts
Mar 18
long term calcium and vit d outcomes
Mar 18
RWCS Spondyloarthritis talk
Mar 18
Vaccines and SLE
Mar 18
leflunomide RWCS talk
Mar 17
Izokibep press release
Mar 17
aging brain increases pain
Feb 01
?increased male fertility with IJD
Jan 29
Diet talk at rheumnow live
Jan 29
working on vacations
Jan 29
New rule for Prior auths
Jan 29
Vibrating belt for osteopenia
Jan 29
Downloads on rheumnow
Jan 29
G2211 add on code for $16
Jan 29
hypocalcemia with denosumab
Jan 29
generic febuxostat
Jan 29
failed trial with auricular vagal nerve
Dec 27
OB outcomes unaffected by TNFs
Dec 27
Pizza improves RA!
Dec 27
increased fractures with pseudogout
Dec 27
SGLT2i treatment reduces gout flares
Dec 27
Denosumab reduces diabetes
Dec 27
ankylosing spondylitis is outdated
Dec 27
Social determinants of health
Dec 27
Dupilumab associated arthritis
Dec 27
AWIR annual conference
Dec 27
hs-cTnT
Dec 01
UPA affects on direct and indirect pain
Dec 01
In vitro clot formation with Tofacitinib
Dec 01
Glococorticoids increasing MACE
Dec 01
TNFs ok to use with RA ILD
Dec 01
APIPPRA RA prévention
Dec 01
PRO pain with deucravacitinib
Dec 01
Undiagnosed IBD
Dec 01
PJP prophylaxis with Rituxan
Nov 30
Guidelines for timing of arthroplasty
Nov 30
Methotrexate lowers BP
Nov 16
IRIS-RA
Nov 16
JAK failures: switching vs cycling
Nov 16
Medicarion induced arthritis
Nov 16
Saliclick device for salivary biopsy
Nov 16
private practice basics
Nov 16
AWIR
Nov 12
improved synovial crystal identification
Nov 12
Green light therapy
Nov 12
Steps and BMI rinvoq response
Nov 12
New EULAR SLE recs
Oct 30
PMR treatment options
Oct 30
JAKs in the RABBIT registry
Oct 30
Antimalarial adherence reduces CVD risk
Oct 29
PRESTO took to calculate risk of PSA
Oct 29
Ozoralizumab, a TNF nano body
Oct 29
exercise in PMR
Oct 29
BE OPTIMAL, BE MOBILE
Oct 29
IV secukinumab approved
Oct 29
Bimzelx approved for psoriasis
Oct 29
RA pt concerns about treatment
Sep 27
Loading logo

RemoveCancel